title: Independent data about the safety and efficacy of rivaroxaban for prevention of stroke/embolism are needed: Author reply.
authors.affiliation: Center for Vascular Medicine and Department of Medicine III, Division of Angiology, University Hospital 'Carl Gustav Carus' Dresden, Fetscherstrasse 74, Dresden D-01307, Germany jan.beyer@uniklinikum-dresden.de.
authors.forename: Jan
authors.initials: J
authors.lastname: Beyer-Westendorf
mesh_terms: D001281:Atrial Fibrillation / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D012042:Registries; D000069552:Rivaroxaban / Q000008:administration & dosage*; D020521:Stroke / Q000517:prevention & control*; D028761:Withholding Treatment / Q000706:statistics & numerical data*
chemical_list: D000069552:Rivaroxaban